For women with type 1 diabetes (T1D), becoming pregnant and having a healthy pregnancy raise many questions. But planning a pregnancy or adjusting to pregnant life as a person with T1D doesn’t have to be stressful. We asked Gina Capone, JDRF’s community manager for TypeOneNation and first-time mother with T1D, to share her pregnancy story [...]
Living with type 1 diabetes (T1D) requires constant care and attention: blood-glucose monitoring, carbohydrate counting, insulin dosing, and monitoring for high and low blood-glucose levels. But new technology is changing T1D management—and for the good. Just ask Tom Brobson, JDRF’s national director of research investment opportunities, who has doubled as a test subject for JDRF’s [...]
When most people with type 1 diabetes (T1D) think about hormones, insulin is usually the first one that comes to mind—people with T1D use it daily to survive. But it takes more than just insulin to regulate blood-glucose levels. Hormones act as chemical messengers in the human body—they are released by a cell, organ, or [...]
Leading experts from industry, academia, and government came together in early April in Bethesda, MD, to discuss innovation in the development of an artificial pancreas at a workshop hosted by the National Institutes of Health, the Food and Drug Administration (FDA), and JDRF. Artificial pancreas systems will automate insulin delivery and likely other hormones in [...]
Shared connections to type 1 diabetes (T1D) brought together more than 600 people at the recent JDRF Type 1 Diabetes Research Summit held in Washington, D.C. Hosted by the JDRF Capitol Chapter, this one-day event was filled with informative, easy-to-understand presentations by top T1D researchers. Attendees had the opportunity to hear directly from these top [...]
For people living with type 1 diabetes (T1D), establishing insulin independence by implanting insulin-producing beta cells into the body would be life changing. But a challenge to this potential therapy lies in the body’s immune system, which recognizes the implanted beta cells as foreign entities or invaders and subsequently attacks them. Furthermore, the implanted beta [...]
Leading experts from industry, academia, and government came together the second week of April in Bethesda, MD, to discuss innovation in the development of an artificial pancreas system at a workshop hosted by the National Institutes of Health, the Food and Drug Administration (FDA), and JDRF. A commercially-viable artificial pancreas system would mimic the biological [...]
Every day, JDRF leverages the expertise and innovation of distinguished researchers from across the globe to support research for life-changing treatments and ultimately a cure for type 1 diabetes (T1D). Our mission aims to serve everybody with T1D—at all ages and stages of the disease. Please enjoy reading about some of the most recent advances [...]
Controlling blood-glucose levels may be first and foremost on the minds of people with type 1 diabetes (T1D), but managing risk factors for heart disease should also be a priority. People with T1D have a higher risk of developing heart disease—conditions that include heart attack, congestive heart failure, and stroke. Because of this, keeping blood [...]
Can a daily multivitamin help lower a person’s chance of getting cancer? According to a recent report from the Journal of the American Medical Association, it might—but only for middle-aged and older men. In a study that followed nearly 15,000 male physicians over the age of 50 for an average of 11 years, daily multivitamin [...]
